T-cell re-population in HIV-infected children on highly active anti-retroviral therapy (HAART)

DJS King, FM Gotch… - Clinical & Experimental …, 2001 - academic.oup.com
DJS King, FM Gotch, EL Larsson-Sciard
Clinical & Experimental Immunology, 2001academic.oup.com
In this pilot study, we address the nature of the re-population of the T-cell compartment in
HIV-1+(Human Immunodeficiency Virus 1), vertically infected children placed on successful
regimens of HAART (highly active anti-retroviral therapy) incorporating 2 NRTI and a
protease inhibitor. The clonality of the T-cell compartment and the abundance of RTEs
(Recent Thymic Emigrants) were determined 2 weeks before and 20 weeks after initiation of
HAART in a subgroup of children taking part in the PENTA (Paediatric European Network for …
Summary
In this pilot study, we address the nature of the re-population of the T-cell compartment in HIV-1+ (Human Immunodeficiency Virus 1), vertically infected children placed on successful regimens of HAART (highly active anti-retroviral therapy) incorporating 2 NRTI and a protease inhibitor. The clonality of the T-cell compartment and the abundance of RTEs (Recent Thymic Emigrants) were determined 2 weeks before and 20 weeks after initiation of HAART in a subgroup of children taking part in the PENTA (Paediatric European Network for the Treatment of AIDS) 5 trial. Analysis of the clonality of the circulating T-cell compartment was assessed using CDR3 spectratyping and analysed using the Kolmogorov–Smirnov two sample test. This revealed that a high degree of T-cell clonal restriction still exists 5 months into therapy, despite the appearance of previously undetectable T-cell clones within the periphery. We detected no increase in RTE abundance in this 5 month period, as determined by PCR detection of TRECs (T-Cell Receptor Excision Circles). We conclude that the observed re-population of T cells within the periphery of treated children is heavily reliant upon the maintenance/expansion of pre-existing cells during the 5 month period immediately following the initiation of therapy.
Oxford University Press